Overview

The market context and the core strategic thesis. Start here for the macro frame — what is happening in AI × Bio in 2026, and what we believe about it.

Three facts define the opportunity: autonomous labs have crossed from demo to commercial product; India holds the world's most diverse patient populations but no indigenous discovery platform; and Apollo Hospitals offers a contracted clinical substrate that global players cannot replicate with capital alone.